| 000 | 01718 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514065819.0 | ||
| 264 | 0 | _c20040123 | |
| 008 | 200401s 0 0 eng d | ||
| 022 | _a1535-7163 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aScott, Kate A | |
| 245 | 0 | 0 |
_aAn anti-tumor necrosis factor-alpha antibody inhibits the development of experimental skin tumors. _h[electronic resource] |
| 260 |
_bMolecular cancer therapeutics _cMay 2003 |
||
| 300 |
_a445-51 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_a9,10-Dimethyl-1,2-benzanthracene _xtoxicity |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinogens _xtoxicity |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGranulocyte-Macrophage Colony-Stimulating Factor _xmetabolism |
| 650 | 0 | 4 | _aImmunity, Innate |
| 650 | 0 | 4 |
_aKeratinocytes _xdrug effects |
| 650 | 0 | 4 |
_aMammary Neoplasms, Experimental _xdrug therapy |
| 650 | 0 | 4 |
_aMatrix Metalloproteinase 9 _xmetabolism |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aPapilloma _xchemically induced |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aSkin Neoplasms _xchemically induced |
| 650 | 0 | 4 |
_aTetradecanoylphorbol Acetate _xtoxicity |
| 650 | 0 | 4 |
_aTransforming Growth Factor alpha _ximmunology |
| 700 | 1 | _aMoore, Robert J | |
| 700 | 1 | _aArnott, Caroline H | |
| 700 | 1 | _aEast, Nick | |
| 700 | 1 | _aThompson, Richard G | |
| 700 | 1 | _aScallon, Bernard J | |
| 700 | 1 | _aShealy, David J | |
| 700 | 1 | _aBalkwill, Frances R | |
| 773 | 0 |
_tMolecular cancer therapeutics _gvol. 2 _gno. 5 _gp. 445-51 |
|
| 999 |
_c12536709 _d12536709 |
||